Adverse Event Reporting Policy

Comment on this policy

Being committed to the continuing availability of medicinal products that are pure, safe, potent and efficacious for animals, the AVMA encourages continued development and strengthening of adverse event reporting systems. This includes continued collaboration with constituent professional organizations, industry organizations, government entities and other stakeholders.

See also: Reporting adverse events

Background:

AVMA Brochure: Veterinary Biologics